RET and thyroid gland carcinoma: Subsequently, Moretti and coworkers proved that RET/PTC3 induces IDO1 expression through full activation of STAT1-IRF1 pathway, demonstrating a direct link between this immunosuppressive enzyme and the oncogenic activation of RET in thyroid carcinoma (85).